← Browse by Condition
Medical Condition
soft tissue sarcoma
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 3, Phase 2, Phase 1
NCT06760221
Recruiting
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
Enrollment
20 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Enrollment
325 pts
Location
United States, China...
Sponsor
Advenchen Laboratories, LLC
NCT05950594 Phase 2
Recruiting
IVIM & OLINK in Sarcoma
Enrollment
145 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT05051059
Recruiting
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
Enrollment
60 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT04921917
Recruiting
Exercise and Soft Tissue Sarcoma
Enrollment
24 pts
Location
United States
Sponsor
Duke University
NCT07261631 Phase 1
Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Enrollment
180 pts
Location
Canada, France, Isra...
Sponsor
Novartis Pharmaceuticals
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT05057195
Recruiting
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
Enrollment
78 pts
Location
Russia
Sponsor
Blokhin's Russian Cancer Resea...
NCT05111964
Recruiting
HIFU Ablation of Soft Tissue Sarcoma
Enrollment
10 pts
Location
United Kingdom
Sponsor
Oxford University Hospitals NH...
NCT05301764 Phase 1, Phase 2
Recruiting
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
Enrollment
65 pts
Location
China
Sponsor
Lyvgen Biopharma Holdings Limi...
NCT05755113 Phase 2
Recruiting
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Enrollment
40 pts
Location
United States
Sponsor
QBiotics Group Limited
NCT05264974 Phase 1
Recruiting
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Enrollment
18 pts
Location
United States
Sponsor
University of Florida